Earnings Call · Q3 FY2025·2025-10-29

Q3 25EPS +83.33%·Rev n/aQ2 25EPS +100.00%*·Rev n/aQ1 25EPS +100.00%*·Rev n/aQ4 24EPS -13.64%·Rev n/a⚠ consensus missing

TransMedics Group, Inc. TMDX

Dorothy Morgan — Investor Relations or Communications

Waleed Hassanein — President & CEO

Gerardo Hernandez — Chief Financial Officer

+1.1%1d on move date+2.2% vs SPY3d−7.1%5d−7.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TMDX calls or request research access.

More TMDX calls Browse calls Request research access